Second, these medications have additional benefits such as weight loss and reduced cardiovascular risk, making them appealing therapeutic options
Nauck MA, Frid A, Hermansen K, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 121.Kinzig KP, DAlessio DA, Herman JP, Sakai RR, Vahl TP, Figueiredo HF, Murphy EK, Seeley RJ
Compare provider-reviewed options Research Snapshot Ranked provider guide Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages
and Asia, providing customers a seamless and reliable shopping experience
Prescription GLP-1 receptor agonists may be indicated for adults with type 2 diabetes not meeting glycemic targets, those with established cardiovascular disease or chronic kidney disease, or individuals with obesity and weight-related complications when lifestyle interventions prove insufficient